We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. Biotech & pharma: unique business in history
- Dr. Radi Haloub
-
2. Environmental aspects and changes in health systems
- Dr. Radi Haloub
-
3. Why do pharmaceutical companies exist?
- Dr. Radi Haloub
-
4. Capability and capacity of pharmaceutical business
- Dr. Radi Haloub
-
5. Culture and structure in the pharmaceutical industry
- Dr. Radi Haloub
-
6. Scope of the pharmaceutical companies: corporate level- Dr. Radi Haloub
-
8. Overseas and beyond in pharmaceutical business
- Dr. Radi Haloub
-
9. Future technologies in biotech and pharmaceutical companies
- Dr. Radi Haloub
-
10. Mergers and acquisitions in the pharmaceutical industry
- Dr. Radi Haloub
Printable Handouts
Navigable Slide Index
This material is restricted to subscribers.
Topics Covered
- Product development
- Digital transformation of the pharmaceutical industry
- Artificial intelligence (AI)
- Machine learning (ML)
- Quantum computing (QC)
- Blockchain
Links
Series:
Categories:
External Links
- Slide 11: Evers, M., Heid, A., & Ostojic, I. (2021) Pharma’s digital Rx: Quantum computing in drug research and development. McKinsey and Company
- Slide 11: Stanford Report (2024). Stanford explainer: CRISPR, gene editing, and beyond.
- Slide 11: Gene, Cell, & RNA Therapies Landscape Report, Q2 2024 Quarterly Data Report. American Society of Gene & Cell Therapy. Citeline. 2024
Talk Citation
Haloub, R. (2026, February 26). Future technologies in biotech and pharmaceutical companies [Video file]. In The Business & Management Collection, Henry Stewart Talks. Retrieved April 19, 2026, from https://doi.org/10.69645/EQBT2915.Export Citation (RIS)
Publication History
- Published on February 26, 2026
A selection of talks on Management, Leadership & Organisation
Transcript
Please wait while the transcript is being prepared...
0:00
Hi, everyone. Today, we're going
to talk about the
future technologies
in biotech and
pharmaceutical companies.
This is Radi Haloub.
I'm an associate professor
and program lead for
the biotech and pharmaceutical
management program
at UCL Global Business
School for Health.
0:17
The aim of this session
today is to illustrate
the variations between companies
in the development
of new products.
I will also talk about
the application of
emerging technologies
that are shaping
the evolution of
the biotechnology and
pharmaceutical industries.
0:36
I will start with new
product development.
It's identifying and developing
small molecules
and macromolecules
that might help cure
illnesses and diseases
which is the core activity
of pharmaceutical companies.
The changes in the
environment impact innovation
within the industry
and influence
how these innovations
are perceived.
These innovation
initiatives define
the variations between companies
and affect their competitiveness
and potential for
market expansion.
It also affects companies'
ability to cope
with changes in the
scientific landscape,
and how they will diversify
their product
portfolios to remain
competitive and
sustain their revenue.
However, technology is not
always easy to obtain,
and suppliers rarely offer it
exclusively to a single company.
This has influenced
the relationships
between companies and prompt
the development of various forms
of technology sharing
through partnerships.
1:39
Now moving to the
future technologies
and the rationale for change.
Pharmaceutical and
biotech companies
are research-based industries.
The research is
constantly evolving,
and demands from healthcare
continue to change.
The technology is
driven by competition
and their ability to
sustain their business.
Miozza, Brunetta, and Appio
published an article titled
Digital Transformation of
the Pharmaceutical Industry:
A Future Research Agenda
for Management Studies.
They contributed and enriched
the ongoing conversation
around the digital
transformation
of pharmaceutical companies.
This transformation is
widely acknowledged
as a key factor in advancing
healthcare outcomes.